Treatment of malignant hypertension. The influence of etiology on the survival in 12 consecutive patients.
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D004039:Diet, Sodium-Restricted; D004176:Dipyridamole / Q000627:therapeutic use; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006974:Hypertension, Malignant / Q000209:etiology / Q000628:therapy*; D007674:Kidney Diseases / Q000150:complications; D008297:Male; D010530:Peritoneal Dialysis; D011379:Prognosis; D006435:Renal Dialysis
D000959:Antihypertensive Agents; D004176:Dipyridamole; D005665:Furosemide; D006493:Heparin